Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing Human Immunodeficiency Virus (HIV)-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn Infants - Concepedia

Concepedia

Publication | Open Access

Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing Human Immunodeficiency Virus (HIV)-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn Infants

DOI Full Paper Access

56

Citations

23

References

2019

Year

Coleen K. Cunningham, Elizabeth J. McFarland, R. L. Morrison, Edmund V. Capparelli, Jeffrey T. Safrit, Lynne Mofenson, Bonnie J. Mathieson, Megan Valentine, Charlotte Perlowski, Betsy Smith,

The Journal of Infectious Diseases

Abstract

Subcutaneous VRC01 as single or multiple doses is safe and well tolerated in very young infants and is suitable for further study to prevent HIV transmission in infants.

References

	Year	Citations

Page 1